Prognostic Value of MCM2 Immunoreactivity in Stage T1 Transitional Cell Carcinoma of the Bladder

Author: Kruger S.   Thorns C.   Stocker W.   Muller-Kunert E.   Bohle A.   Feller A.C.  

Publisher: Elsevier

ISSN: 0302-2838

Source: European Urology, Vol.43, Iss.2, 2003-02, pp. : 138-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content